Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer
Clinical trial NCT03971045 · RECRUITING
Trial details
- NCT number
- NCT03971045
- Sponsor
- European Institute of Oncology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2024-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.